Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1799788 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $12.80Day −4.83%Mkt cap $188M1Y +15.0%Off 52W high −62.5%Vol (1Y) 100.3%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,360 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.0% of sh out |
| Days to cover12.1d |
| 13F net flow (QoQ)+1.35% |
| Top-10 13F concentration80.3% |
| Next report (est.)2026-09-01 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$22.3M |
| ROE−3068.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−39.1% |
| 1Y+15.0% |
| 3Y+39.1% |
| 5Y−67.6% |
| Since incept. (ann.)−17.1% |
Total return through 2026-07-29 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)100.3% |
| Ann. volatility (3Y)78.7% |
| Sharpe (1Y)0.60 |
| Sharpe (3Y)0.54 |
| Max drawdown (1Y)−61.9% |
| Max drawdown (3Y)−61.9% |
| Beta (3Y vs SPY)2.48 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 433,860 | $10M | 2.96% | +16.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | 298,266 | $7M | 2.03% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 155,466 | $4M | 1.06% | +2.5% |
| STATE STREET CORP | 133,875 | $3M | 0.91% | +36.9% |
| Nuveen, LLC | 88,717 | $2M | 0.60% | new |
| NORTHERN TRUST CORP | 75,125 | $2M | 0.51% | +2.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 58,911 | $1M | 0.40% | new |
| Bank of New York Mellon Corp | 46,523 | $1M | 0.32% | +235.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-06-04 | −$0.39 | — | — | — |
| 2025-09-30 | 2025-11-14 | −$0.27 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.28 | — | — | — |
| 2025-03-31 | 2025-05-20 | −$0.21 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-09-01 is ESTIMATED from filing cadence (median gap 89d) — not company-confirmed.
